Back to 
JANE STREET GROUP, LLC
JANE STREET GROUP, LLC
MBRX2 quarters
Position history for JANE STREET GROUP, LLC's holdings in MOLECULIN BIOTECH INC
No. Jane Street Group exited its MBRX (Moleculin Biotech) position in Q1 2026. Its Q4 2025 13F listed 22,550 shares worth $74,640. Jane Street Group first reported MBRX in Q4 2025 and held it in 1 quarterly 13F filing.
Final Value
$0
Final Shares
0
Total Value Change
-$74,640
Total Shares Change
-22,550
Quarter-by-Quarter History
Other major holders of MBRX: GEODE CAPITAL MANAGEMENT, LLC, VANGUARD CAPITAL MANAGEMENT LLC, CITADEL ADVISORS LLC, VANGUARD FIDUCIARY TRUST CO